Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia

Lirong Pei, Jeong-Hyeon Choi, Jimei Liu, Eun Joon Lee, Brian McCarthy, James M. Wilson, Ethan Speir, Farrukh Awan, Hongseok Tae, Gerald Arthur, Jennifer L. Schnabel, Kristen H. Taylor, Xinguo Wang, Dong Xu, Hanfei Ding, David H Munn, Charles W. Caldwell, Huidong Shi

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

We conducted a genome-wide DNA methylation analysis in CD19+ B-cells from chronic lymphocytic leukemia (CLL) patients and normal control samples using reduced representation bisulfite sequencing (RRBS). The methylation status of 1.8-2.3 million CpGs in the CLL genome was determined; about 45% of these CpGs were located in more than 23,000 CpG islands (CGIs). While global CpG methylation was similar between CLL and normal B-cells, 1,764 gene promoters were identified as being differentially methylated in at least one CLL sample when compared with normal B-cell samples. Nineteen percent of the differentially methylated genes were involved in transcriptional regulation. Aberrant hypermethylation was found in all HOX gene clusters and a significant number of WNT signaling pathway genes. Hypomethylation occurred more frequently in the gene body including introns, exons and 3'-UTRs in CLL. The NFATc1 P2 promoter and first intron was found to be hypomethylated and correlated with upregulation of both NFATc1 RNA and protein expression levels in CLL suggesting that an epigenetic mechanism is involved in the constitutive activation of NFAT activity in CLL cells. This comprehensive DNA methylation analysis will further our understanding of the epigenetic contribution to cellular dysfunction in CLL.

Original languageEnglish (US)
Pages (from-to)567-578
Number of pages12
JournalEpigenetics
Volume7
Issue number6
DOIs
StatePublished - Jan 1 2012

Fingerprint

DNA Methylation
B-Cell Chronic Lymphocytic Leukemia
Epigenomics
Genome
Introns
Methylation
Genes
CpG Islands
3' Untranslated Regions
Multigene Family
Exons
B-Lymphocytes
Up-Regulation
RNA

Keywords

  • Chronic lymphocytic leukemia
  • DNA methylation
  • NFATc1
  • Next-generation sequencing
  • Reduced representation bisulfite sequencing

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia. / Pei, Lirong; Choi, Jeong-Hyeon; Liu, Jimei; Lee, Eun Joon; McCarthy, Brian; Wilson, James M.; Speir, Ethan; Awan, Farrukh; Tae, Hongseok; Arthur, Gerald; Schnabel, Jennifer L.; Taylor, Kristen H.; Wang, Xinguo; Xu, Dong; Ding, Hanfei; Munn, David H; Caldwell, Charles W.; Shi, Huidong.

In: Epigenetics, Vol. 7, No. 6, 01.01.2012, p. 567-578.

Research output: Contribution to journalArticle

Pei, L, Choi, J-H, Liu, J, Lee, EJ, McCarthy, B, Wilson, JM, Speir, E, Awan, F, Tae, H, Arthur, G, Schnabel, JL, Taylor, KH, Wang, X, Xu, D, Ding, H, Munn, DH, Caldwell, CW & Shi, H 2012, 'Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia', Epigenetics, vol. 7, no. 6, pp. 567-578. https://doi.org/10.4161/epi.20237
Pei, Lirong ; Choi, Jeong-Hyeon ; Liu, Jimei ; Lee, Eun Joon ; McCarthy, Brian ; Wilson, James M. ; Speir, Ethan ; Awan, Farrukh ; Tae, Hongseok ; Arthur, Gerald ; Schnabel, Jennifer L. ; Taylor, Kristen H. ; Wang, Xinguo ; Xu, Dong ; Ding, Hanfei ; Munn, David H ; Caldwell, Charles W. ; Shi, Huidong. / Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia. In: Epigenetics. 2012 ; Vol. 7, No. 6. pp. 567-578.
@article{e7d808b07e3d4e5bb428578cff31f1e8,
title = "Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia",
abstract = "We conducted a genome-wide DNA methylation analysis in CD19+ B-cells from chronic lymphocytic leukemia (CLL) patients and normal control samples using reduced representation bisulfite sequencing (RRBS). The methylation status of 1.8-2.3 million CpGs in the CLL genome was determined; about 45{\%} of these CpGs were located in more than 23,000 CpG islands (CGIs). While global CpG methylation was similar between CLL and normal B-cells, 1,764 gene promoters were identified as being differentially methylated in at least one CLL sample when compared with normal B-cell samples. Nineteen percent of the differentially methylated genes were involved in transcriptional regulation. Aberrant hypermethylation was found in all HOX gene clusters and a significant number of WNT signaling pathway genes. Hypomethylation occurred more frequently in the gene body including introns, exons and 3'-UTRs in CLL. The NFATc1 P2 promoter and first intron was found to be hypomethylated and correlated with upregulation of both NFATc1 RNA and protein expression levels in CLL suggesting that an epigenetic mechanism is involved in the constitutive activation of NFAT activity in CLL cells. This comprehensive DNA methylation analysis will further our understanding of the epigenetic contribution to cellular dysfunction in CLL.",
keywords = "Chronic lymphocytic leukemia, DNA methylation, NFATc1, Next-generation sequencing, Reduced representation bisulfite sequencing",
author = "Lirong Pei and Jeong-Hyeon Choi and Jimei Liu and Lee, {Eun Joon} and Brian McCarthy and Wilson, {James M.} and Ethan Speir and Farrukh Awan and Hongseok Tae and Gerald Arthur and Schnabel, {Jennifer L.} and Taylor, {Kristen H.} and Xinguo Wang and Dong Xu and Hanfei Ding and Munn, {David H} and Caldwell, {Charles W.} and Huidong Shi",
year = "2012",
month = "1",
day = "1",
doi = "10.4161/epi.20237",
language = "English (US)",
volume = "7",
pages = "567--578",
journal = "Epigenetics",
issn = "1559-2294",
publisher = "Landes Bioscience",
number = "6",

}

TY - JOUR

T1 - Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia

AU - Pei, Lirong

AU - Choi, Jeong-Hyeon

AU - Liu, Jimei

AU - Lee, Eun Joon

AU - McCarthy, Brian

AU - Wilson, James M.

AU - Speir, Ethan

AU - Awan, Farrukh

AU - Tae, Hongseok

AU - Arthur, Gerald

AU - Schnabel, Jennifer L.

AU - Taylor, Kristen H.

AU - Wang, Xinguo

AU - Xu, Dong

AU - Ding, Hanfei

AU - Munn, David H

AU - Caldwell, Charles W.

AU - Shi, Huidong

PY - 2012/1/1

Y1 - 2012/1/1

N2 - We conducted a genome-wide DNA methylation analysis in CD19+ B-cells from chronic lymphocytic leukemia (CLL) patients and normal control samples using reduced representation bisulfite sequencing (RRBS). The methylation status of 1.8-2.3 million CpGs in the CLL genome was determined; about 45% of these CpGs were located in more than 23,000 CpG islands (CGIs). While global CpG methylation was similar between CLL and normal B-cells, 1,764 gene promoters were identified as being differentially methylated in at least one CLL sample when compared with normal B-cell samples. Nineteen percent of the differentially methylated genes were involved in transcriptional regulation. Aberrant hypermethylation was found in all HOX gene clusters and a significant number of WNT signaling pathway genes. Hypomethylation occurred more frequently in the gene body including introns, exons and 3'-UTRs in CLL. The NFATc1 P2 promoter and first intron was found to be hypomethylated and correlated with upregulation of both NFATc1 RNA and protein expression levels in CLL suggesting that an epigenetic mechanism is involved in the constitutive activation of NFAT activity in CLL cells. This comprehensive DNA methylation analysis will further our understanding of the epigenetic contribution to cellular dysfunction in CLL.

AB - We conducted a genome-wide DNA methylation analysis in CD19+ B-cells from chronic lymphocytic leukemia (CLL) patients and normal control samples using reduced representation bisulfite sequencing (RRBS). The methylation status of 1.8-2.3 million CpGs in the CLL genome was determined; about 45% of these CpGs were located in more than 23,000 CpG islands (CGIs). While global CpG methylation was similar between CLL and normal B-cells, 1,764 gene promoters were identified as being differentially methylated in at least one CLL sample when compared with normal B-cell samples. Nineteen percent of the differentially methylated genes were involved in transcriptional regulation. Aberrant hypermethylation was found in all HOX gene clusters and a significant number of WNT signaling pathway genes. Hypomethylation occurred more frequently in the gene body including introns, exons and 3'-UTRs in CLL. The NFATc1 P2 promoter and first intron was found to be hypomethylated and correlated with upregulation of both NFATc1 RNA and protein expression levels in CLL suggesting that an epigenetic mechanism is involved in the constitutive activation of NFAT activity in CLL cells. This comprehensive DNA methylation analysis will further our understanding of the epigenetic contribution to cellular dysfunction in CLL.

KW - Chronic lymphocytic leukemia

KW - DNA methylation

KW - NFATc1

KW - Next-generation sequencing

KW - Reduced representation bisulfite sequencing

UR - http://www.scopus.com/inward/record.url?scp=84861922114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861922114&partnerID=8YFLogxK

U2 - 10.4161/epi.20237

DO - 10.4161/epi.20237

M3 - Article

VL - 7

SP - 567

EP - 578

JO - Epigenetics

JF - Epigenetics

SN - 1559-2294

IS - 6

ER -